Two acoustics from Cort’s China-based workshop that couldn’t be further apart in style, from the traditional overtones of the ...

Corcept Therapeutics Incorporated (CORT) stock saw a modest uptick, ending the day at $45.43 which represents a slight increase of $0.39 or 0.87% from the prior close of $45.04. The stock opened at ...

The average of price targets set by Wall Street analysts indicates a potential upside of 41.3% in Corcept (CORT). While the effectiveness of this highly sought-after metric is questionable ...

On Monday, Corcept Therapeutics Incorporated (CORT) stock saw a modest uptick, ending the day at $46.28 which represents a slight increase of $2.35 or 5.35% from the prior close of $43.93. The stock ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

In a report released today, Joon Lee from Truist Financial maintained a Buy rating on Corcept Therapeutics (CORT – Research Report), with ...

Canaccord Genuity maintained its Buy rating and $78.00 price target for NASDAQ:CORT, Corcept Therapeutics (NASDAQ:CORT). The firm highlighted the company's solid performance as the third quarter comes ...

Corcept Shares Rise More Than 45% in Six Months: Here's Why Shares of Corcept Therapeutics Incorporated (NASDAQ: CORT) have gained 46.2% in the past six months against the industry's decline of 2%.

ClearBridge Investments, an investment management company, released its “ClearBridge Small Cap Value Strategy” second quarter ...

In a report released today, Joon Lee from Truist Financial assigned a Buy rating to Corcept Therapeutics (CORT – Research Report). The ...